No Data
No Data
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersSharps Technology (NASDAQ:STSS) shares rose 193.0% to $0.63 during Tuesday's pre-market session. The market value of their outstanding shares is at $9.8 million. Insmed (NASDAQ:INSM) shares mov
EFFECTOR Therapeutics And Dana-Farber Cancer Institute To Collaborate On Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin As Combination Treatment In ER+ Endometrial Cancer And In Low Grade Serous Ovarian Cancer
EFFECTOR Therapeutics And Dana-Farber Cancer Institute To Collaborate On Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin As Combination Treatment In ER+ Endometrial Cancer And In Lo
Effector Therapeutics (EFTR.US): The 2024 Q1 financial report achieved revenue of $0, previous value of $0; earnings per share of -$2.16, previous value of -$6.00, expected value of -$2.16.
Effector Therapeutics (EFTR.US): The 2024 Q1 financial report achieved revenue of $0, previous value of $0; earnings per share of -$2.16, previous value of -$6.00, expected value of -$2.16.
EFFECTOR Therapeutics Q1 2024 GAAP EPS $(2.16) Beats $(2.17) Estimate; Reports Cash Runway Into Q1 Of 2025
eFFECTOR Therapeutics (NASDAQ:EFTR) reported quarterly losses of $(2.16) per share which beat the analyst consensus estimate of $(2.17) by 0.46 percent.
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersSensus Healthcare (NASDAQ:SRTS) shares increased by 33.3% to $5.08 during Thursday's after-market session. The market value of their outstanding shares is at $83.2 million. As per the news, the
10-Q: Quarterly report